About Us
Contact Us
Career
Payments
Login
Online Trading
New Backoffice
×
About Us
Contact Us
Career
Payments
Login
Online Trading
New Backoffice
Smaart Trade
Client/AP/Branch Setup
Online Trading
Mobile Login
Smaart Trade EXE Help File
Smaart Trade Mobile Help File
Re-KYC
Stock Market Course
Investor Corner
Nominate Online
Open An Account Online
Market Information
Stock Market
News
Equity
Company Info
Mutual Fund
IPO
EOD 4278863
Live Quotes
Company Profile
Board of Directors
Income Statement
Balance Sheet
Ratio Analysis
Cash Flow
Annual Results
Quarterly Results
Half Yearly Results
Shareholding
Change Name
MF Holding
Locations
Board Meetings
Corporate News
Investors Return
Bankers/Auditors
Technical Chart
Balance Sheet
Ratio Analysis
Cash Flow
Annual Results
Quarterly Results
Half Yearly Results
Shareholding
Change Name
MF Holding
Locations
Board Meetings
Corporate News
Investors Return
COMPANY PROFILE
The profile page of the company captures the details on Registered Office, Registrar & Share Transfer Agent, Key Officials, Recent News.
Novartis India Ltd.
GO
Feb 20
BSE
996.50
(+ 166.05 20.00%)
Volume
1034421
Prev. Close
830.45
Open Price
904.00
Today's Low / High
904.00
996.50
Bid. Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
52 Wk Low / High
744.95
1099.90
Novartis India Ltd.is not traded in NSE
Registered Address
Mumbai, Maharashtra - 400051
Tel: 22-50243000
Fax: 22-50243010
Email :
india.investors@novartis.com
Website :
http://www.novartis.in
,
Mumbai, Maharashtra - 400051
Tel: 22-50243000,Fax: 22-50243010
Website :
http://www.novartis.in
Email :
india.investors@novartis.com
Registrar Details
MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel :
022-49186270
Fax :
49186060
Key Officials
Name
Designation
Mr. Christopher Snook
Chairperson
Ms. Chandni Maru
Co. Secretary & Compl. Officer
Other Details
Business Group
Novartis AG
BSE Code
500672
NSE Code
Listings
BSE
ISIN No.
INE234A01025
Corporate News
Date
Headline
20/02/2026
Novartis - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
29/01/2026
Novartis - Rumour verification - Regulation 30(11)
28/01/2026
Novartis Q3 net profit down 36.78% at Rs 16.09 cr
28/01/2026
Novartis - Integrated Filing (Financial) For The Quarter Ended December 31, 2025.
Become a Authorised Person / Franchise
Become a Authorised Person / Franchise
Become a Authorised Person / Franchise
Market Information
Market Information
Market Information
Open An Account Online
Open An Account Online
Open An Account Online
IPO Online
IPO Online
IPO Online
Mutual Fund
Mutual Fund
Mutual Fund
Login
Login
Login
RTA
RTA
Registrar and Transfer Agent(RTA)
Services
Services
Services
Research
Research
Research
Chat
Chat
Chat
Call
Call
Call
script src="IndexNew/js/jquery.min.js">